Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents

Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. We determined hepatitis B virus (HBV) suppression rates among 18 lamivudine (3TC)-experienced HBV-human immunodeficiency virus-coinfected adolescents after treatment with tenofovir disoproxil fumurate (TDF). At TDF initiation, their m...

Saved in:

書目詳細資料
Main Authors:	Aurpibul L., Lumbiganon P., Hansudewechakul R., Kanjanavanit S., Bunupuradah T., Kosalaraksa P., Taeprasert P., Puthanakit T.
格式:	雜誌
出版:	2017
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85007247655&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40623
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
由: Linda Aurpibul, et al.
出版: (2018)

Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
由: Linda Aurpibul, et al.
出版: (2018)

HIV and hepatitis B coinfection among perinatally HIV-infected thai adolescents
由: Aurpibul L., et al.
出版: (2017)

HIV and hepatitis B coinfection among perinatally HIV-infected thai adolescents
由: Linda Aurpibul, et al.
出版: (2018)

Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
由: Linda Aurpibul, et al.
出版: (2019)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
由: Tavitiya Sudjaritruk, et al.
出版: (2018)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
由: Tavitiya Sudjaritruk, et al.
出版: (2018)

SAFETY USE OF COMBINATION TENOFOVIR-LAMIVUDINE-DOLUTEGRAVIR COMPARED WITH TENOFOVIR-LAMIVUDINE-EFAVIRENZ IN HIV PATIENTS AT IBRAHIM ADJIE COMMUNITY HEALTH CENTER BANDUNG
由: Zidan Fikri Akromy, Muhammad

EFFECTIVENESS OF TENOFOVIR-LAMIVUDIN-EFAVIRENZ (TLE) COMBINATION COMPARED TO TENOFOVIR-LAMIVUDIN- DOLUTEGRAVIR (TLD) IN HIV PATIENTS AT UPTD PUSKESMAS IBRAHIM ADJIE BANDUNG
由: Basuki

Review of tenofovir use in HIV-infected children
由: Linda Aurpibul, et al.
出版: (2018)

Review of tenofovir use in HIV-infected children
由: Linda Aurpibul, et al.
出版: (2018)

Comparison of thai government manufactured tenofovir (Tenofovir GPO300) with privately manufactured tenofovir (Viread) used along with lamivudine and efavirenz to treat Thai HIV patients
由: Weerawat Manosuthi, et al.
出版: (2018)

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
由: Avihingsanon A.
出版: (2023)

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
由: G. Jourdain, et al.
出版: (2018)

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
由: G. Jourdain, et al.
出版: (2018)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
由: Weerawat Manosuthi, et al.
出版: (2018)

Tenofovir for children and adults with chronic hepatitis B
由: Li, Huijuan, et al.
出版: (2023)

Telbivudine versus lamivudine in patients with chronic hepatitis B
由: Ching Lung Lai, et al.
出版: (2018)

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
由: Gonzague Jourdain, et al.
出版: (2018)

Coinfections with hepatitis G and/or C virus in hepatitis B-related chronic liver disease
由: Chutima Pramoolsinsap, et al.
出版: (2018)

Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database
由: Linda Aurpibul, et al.
出版: (2019)

Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy
由: Tavitiya Sudjaritruk, et al.
出版: (2020)

Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients
由: Lim, L.L., et al.
出版: (2016)

Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living with HIV: Week 24 Results from IMPAACT 2014
由: Melvin A.J.
出版: (2023)

The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B
由: Marc M. Solomon, et al.
出版: (2018)

The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B
由: Solomon M., et al.
出版: (2017)

Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy
由: Pawinee Wongprasit, et al.
出版: (2018)

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
由: Chang, T.-T., et al.
出版: (2016)

Hypovitaminosis D and hyperparathyroidism: Effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents
由: Sudjaritruk T., et al.
出版: (2017)

Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore
由: Wang, Y.M., et al.
出版: (2014)

Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore
由: Wang, Y.M., et al.
出版: (2016)

A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study
由: Torsak Bunupuradah, et al.
出版: (2018)

Final Height and Associated Factors in Perinatally HIV-infected Asian Adolescents
由: Bunupuradah T., et al.
出版: (2017)

Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: A prospective study
由: Weerawat Manosuthi, et al.
出版: (2018)

PREVALENCE OF HEPATITIS B AND HEPATITIS C VIRUS COINFECTION IN HEMODIALYSIS UNIT, Dr. SARDJITO GENERAL HOSPITAL, YOGYAKARTA
由: , SUNITHA S.SASIKUMAR, et al.
出版: (2014)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: Lau G.K.K., et al.
出版: (2014)

Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics
由: Dan, Y.-Y., et al.
出版: (2016)

Role of Hepatitis C Virus Coinfection in TB Development
由: Pudji Lestari, et al.
出版: (2016)

Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
由: Ingrid A. Beck, et al.
出版: (2018)

Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
由: Beck I., et al.
出版: (2017)